DHFB
MEDP icon

Dixon Hubard Feinour & Brown’s Medpace MEDP Stock Holding History

Dixon Hubard Feinour & Brown’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-29,386
Closed -$4.81M – 295
2022
Q1 		$4.81M Sell
29,386
-28,139
-49% -$4.64M 0.48% 60
2021
Q4 		$12.5M Sell
57,525
-1,000
-2% -$209K 1.21% 21
2021
Q3 		$11.1M Sell
58,525
-7,875
-12% -$1.44M 2.35% 10
2021
Q2 		$11.7M Sell
66,400
-68,175
-51% -$11.8M 2.44% 8
2021
Q1 		$18.5M Buy
134,575
+65,335
+94% +$9.99M 2.27% 10
2020
Q4 		$7.74M Hold
69,240
– – 1.98% 15
2020
Q3 		$7.74M Sell
69,240
-2,260
-3% -$261K 1.98% 15
2020
Q2 		$8.73M Sell
71,500
-2,015
-3% -$171K 2.27% 11
2020
Q1 		$5.39M Sell
73,515
-930
-1% -$80.7K 1.82% 19
2019
Q4 		$6.26M Sell
74,445
-610
-0.8% -$47.2K 1.63% 21
2019
Q3 		$6.31M Buy
75,055
+1,125
+2% +$85K 1.75% 18
2019
Q2 		$4.84M Buy
73,930
+5,245
+8% +$302K 1.37% 25
2019
Q1 		$4.05M Buy
+68,685
New +$4.1M 1.22% 28

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BTW
Boston Trust Walden Boston, Massachusetts $13.1B AUM 24.63% 1-Year Est. Return
ESCM
Echo Street Capital Management New York $747M AUM 24.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Dixon Hubard Feinour & Brown's MEDP Position: Q2 2022 in Review

Dixon Hubard Feinour & Brown sold out of Medpace (MEDP) in Q2 2022, closing a stake of 29,386 shares — an estimated $4.81M sold.

Dixon Hubard Feinour & Brown first reported a position in MEDP in Q1 2019 and held it in 13 quarters. The position peaked at $18.5M in Q1 2021. 340 funds tracked by Wall St. Rank hold MEDP as of Q2 2022.

  • Dixon Hubard Feinour & Brown reported no remaining Medpace position as of Q2 2022 after selling out during the quarter.
  • Dixon Hubard Feinour & Brown sold 29,386 Medpace shares in Q2 2022, an estimated $4.81M.
  • Dixon Hubard Feinour & Brown first reported a position in Medpace in Q1 2019 and held it in 13 quarters.
  • Dixon Hubard Feinour & Brown's Medpace position peaked at $18.5M in Q1 2021.
  • 340 funds tracked by Wall St. Rank held Medpace as of Q2 2022.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2022, filed 22 Jul 2022.